Paper42723950
Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology.
Lu Y and 7 others. Front Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology. Papers, record 42723950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42723950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40244574 | Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2-Positive Locally Advanced Resectable Gastric Cancer: A Randomized Clinical Trial. | JAMA Oncol | 2025 | https://conductscience.org/library/papers/40244574 | PubMed |
| 2 | 19153016 | Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. | Int J Radiat Oncol Biol Phys | 2009 | https://conductscience.org/library/papers/19153016 | PubMed |
| 3 | 32284611 | CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption. | Nat Med | 2020 | https://conductscience.org/library/papers/32284611 | PubMed |
| 4 | 41002563 | Tumor Immune Microenvironment and Current Status of Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Liver Metastasis. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41002563 | PubMed |
| 5 | 38755255 | Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/38755255 | PubMed |
| 6 | 28098136 | Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations. | Nat Commun | 2017 | https://conductscience.org/library/papers/28098136 | PubMed |
| 7 | 28060369 | Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems. | Mod Pathol | 2017 | https://conductscience.org/library/papers/28060369 | PubMed |
| 8 | 17060483 | Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. | Ann Oncol | 2007 | https://conductscience.org/library/papers/17060483 | PubMed |
| 9 | 33531485 | Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution. | Nat Commun | 2021 | https://conductscience.org/library/papers/33531485 | PubMed |
| 10 | 34234122 | Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape. | Nat Commun | 2021 | https://conductscience.org/library/papers/34234122 | PubMed |
| 11 | 12721548 | Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. | Nat Genet | 2003 | https://conductscience.org/library/papers/12721548 | PubMed |
| 12 | 32853711 | Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study. | Int J Radiat Oncol Biol Phys | 2021 | https://conductscience.org/library/papers/32853711 | PubMed |
| 13 | 38473280 | Precision Medicine for Nasopharyngeal Cancer-A Review of Current Prognostic Strategies. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473280 | PubMed |
| 14 | 40209143 | Updates on Treatments and Management of Nasopharyngeal Carcinoma. | Am Soc Clin Oncol Educ Book | 2025 | https://conductscience.org/library/papers/40209143 | PubMed |
| 15 | 31178151 | Nasopharyngeal carcinoma. | Lancet | 2019 | https://conductscience.org/library/papers/31178151 | PubMed |
| 16 | 32983126 | Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment. | Front Immunol | 2020 | https://conductscience.org/library/papers/32983126 | PubMed |
| 17 | 29933636 | Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29933636 | PubMed |
| 18 | 38254110 | Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38254110 | PubMed |
| 19 | 37188668 | Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma. | Nat Commun | 2023 | https://conductscience.org/library/papers/37188668 | PubMed |
| 20 | 40513067 | Anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7 + CD8 + T-cell entry into HCC through high endothelial venules. | Hepatology | 2026 | https://conductscience.org/library/papers/40513067 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| IDO1 | 3620 | PubTator's text mining | https://conductscience.org/library/genes/3620 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42723950
GET https://conductscience.org/api/papers/v1/42723950/references?page=2